应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CLRB Cellectar Biosciences Inc.
休市中 02-21 16:00:00 EST
0.3114
-0.0230
-6.88%
盘后
0.3020
-0.0094
-3.02%
19:31 EST
最高
0.3449
最低
0.3110
成交量
64.54万
今开
0.3400
昨收
0.3344
日振幅
10.14%
总市值
1,435万
流通市值
1,313万
总股本
4,608万
成交额
21.34万
换手率
1.53%
流通股本
4,218万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.53%报0.316美元
市场透视 · 02-21 19:04
Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.53%报0.316美元
Cellectar Biosciences, Inc.盘中异动 早盘大幅拉升7.50%报0.313美元
市场透视 · 02-18
Cellectar Biosciences, Inc.盘中异动 早盘大幅拉升7.50%报0.313美元
Cellectar Biosciences, Inc.盘中异动 股价大涨5.91%报0.298美元
市场透视 · 02-14
Cellectar Biosciences, Inc.盘中异动 股价大涨5.91%报0.298美元
Cellectar Biosciences, Inc.盘中异动 早盘股价大跌9.53%报0.260美元
市场透视 · 02-13
Cellectar Biosciences, Inc.盘中异动 早盘股价大跌9.53%报0.260美元
Cellectar Biosciences, Inc.盘中异动 大幅下挫5.23%
市场透视 · 02-11
Cellectar Biosciences, Inc.盘中异动 大幅下挫5.23%
Cellectar Biosciences, Inc.股价上涨10.04% 市值涨128.09万美元
市场透视 · 02-10
Cellectar Biosciences, Inc.股价上涨10.04% 市值涨128.09万美元
Cellectar Biosciences, Inc.盘中异动 股价大涨5.50%
市场透视 · 02-06
Cellectar Biosciences, Inc.盘中异动 股价大涨5.50%
Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.38%报0.276美元
市场透视 · 02-04
Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.38%报0.276美元
Cellectar Biosciences, Inc.盘中异动 大幅上涨6.60%
市场透视 · 02-03
Cellectar Biosciences, Inc.盘中异动 大幅上涨6.60%
Cellectar Biosciences, Inc.盘中异动 早盘大幅跳水5.32%
市场透视 · 01-28
Cellectar Biosciences, Inc.盘中异动 早盘大幅跳水5.32%
Cellectar Biosciences, Inc.盘中异动 早盘急速下跌6.11%报0.243美元
市场透视 · 01-27
Cellectar Biosciences, Inc.盘中异动 早盘急速下跌6.11%报0.243美元
Cellectar Biosciences, Inc.盘中异动 早盘快速上涨5.00%报0.256美元
市场透视 · 01-24
Cellectar Biosciences, Inc.盘中异动 早盘快速上涨5.00%报0.256美元
Cellectar Biosciences, Inc.盘中异动 急速跳水5.28%
市场透视 · 01-16
Cellectar Biosciences, Inc.盘中异动 急速跳水5.28%
Cellectar Biosciences, Inc.盘中异动 早盘快速下挫6.95%
市场透视 · 01-15
Cellectar Biosciences, Inc.盘中异动 早盘快速下挫6.95%
Cellectar Biosciences, Inc.盘中异动 早盘大幅跳水5.18%报0.267美元
市场透视 · 01-14
Cellectar Biosciences, Inc.盘中异动 早盘大幅跳水5.18%报0.267美元
Cellectar Biosciences, Inc.盘中异动 股价大涨5.56%
市场透视 · 01-13
Cellectar Biosciences, Inc.盘中异动 股价大涨5.56%
Cellectar Biosciences, Inc.盘中异动 早盘急速下跌5.37%
市场透视 · 01-10
Cellectar Biosciences, Inc.盘中异动 早盘急速下跌5.37%
Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.88%
市场透视 · 01-08
Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.88%
Cellectar Biosciences, Inc.盘中异动 股价大涨5.04%
市场透视 · 01-06
Cellectar Biosciences, Inc.盘中异动 股价大涨5.04%
Cellectar Biosciences, Inc.盘中异动 急速上涨5.57%
市场透视 · 01-03
Cellectar Biosciences, Inc.盘中异动 急速上涨5.57%
加载更多
公司概况
公司名称:
Cellectar Biosciences Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日,公司更名为现在的名字。该公司是一家后期临床生物制药公司,专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联物递送平台开发PDC,这些PDC旨在专门针对癌细胞,并由于更少的脱靶效应而提供更好的功效和更好的安全性。
发行价格:
--
{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":0.3114,"timestamp":1740171600000,"preClose":0.3344,"halted":0,"volume":645437,"hourTrading":{"tag":"盘后","latestPrice":0.302,"preClose":0.3114,"latestTime":"19:31 EST","volume":7511,"amount":2328.8701,"timestamp":1740184291914},"delay":0,"floatShares":42179399,"shares":46079876,"eps":-1.920768,"marketStatus":"休市中","change":-0.023,"latestTime":"02-21 16:00:00 EST","open":0.34,"high":0.3449,"low":0.311,"amount":213359.61770318,"amplitude":0.101376,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.920768,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1740387600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.3344,"preHourTrading":{"tag":"盘前","latestPrice":0.34,"preClose":0.3344,"latestTime":"09:10 EST","volume":19545,"amount":6644.12045925,"timestamp":1740147029666},"postHourTrading":{"tag":"盘后","latestPrice":0.302,"preClose":0.3114,"latestTime":"19:31 EST","volume":7511,"amount":2328.8701,"timestamp":1740184291914},"volumeRatio":0.6494048729317007,"impliedVol":0.9174,"impliedVolPercentile":0.4024},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2513347219","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.53%报0.316美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513347219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513347219?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:04","pubTimestamp":1740164660,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时04分,Cellectar Biosciences, Inc.股票出现波动,股价快速下跌5.53%。截至发稿,该股报0.316美元/股,成交量50.4275万股,换手率1.09%,振幅7.75%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.涨幅较大,Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为298.79%、247.85%、136.62%,振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为76.52%、70.25%、61.26%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030420a24ee874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030420a24ee874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2512416530","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅拉升7.50%报0.313美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512416530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512416530?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分,Cellectar Biosciences, Inc.股票出现异动,股价快速上涨7.50%。截至发稿,该股报0.313美元/股,成交量9.5016万股,换手率0.21%,振幅0.00%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为276.23%、91.16%、60.68%,振幅较大的相关个股有Allogene Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Allakos Inc.,振幅分别为9.56%、8.57%、8.35%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223211a24aacc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223211a24aacc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2511611737","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.91%报0.298美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511611737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511611737?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:34","pubTimestamp":1739561694,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时34分,Cellectar Biosciences, Inc.股票出现波动,股价急速拉升5.91%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3108.86%、792.24%、617.89%,振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为74.35%、71.65%、66.45%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215033454abcf45fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215033454abcf45fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2511525178","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌9.53%报0.260美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525178?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:37","pubTimestamp":1739457466,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时37分,Cellectar Biosciences, Inc.股票出现异动,股价大幅下挫9.53%。截至发稿,该股报0.260美元/股,成交量13.1259万股,换手率0.28%,振幅5.18%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Edesa Biotech, Inc.、Dominari Holdings Inc.、Pliant Therapeutics, Inc.涨幅较大,Tc Biopharm Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃,换手率分别为1008.65%、888.51%、98.43%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Edesa Biotech, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为32.86%、25.80%、19.13%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322374798842cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322374798842cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2510886380","title":"Cellectar Biosciences, Inc.盘中异动 大幅下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510886380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284551,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分,Cellectar Biosciences, Inc.股票出现异动,股价快速跳水5.23%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃,换手率分别为2084.07%、546.69%、182.24%,振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为25.06%、22.23%、18.18%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235529881bdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235529881bdc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4139","CLRB"],"gpt_icon":0},{"id":"2510634718","title":"Cellectar Biosciences, Inc.股价上涨10.04% 市值涨128.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510634718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510634718?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197867,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分,Cellectar Biosciences, Inc.股票出现异动,股价急速上涨10.04%。截至发稿,该股报0.330美元/股,成交量50.1161万股,换手率1.09%,振幅0.00%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为1449.95%、834.07%、547.77%,振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm Plc、Kazia Therapeutics Limited,振幅分别为6.44%、5.96%、4.90%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223107a240a1ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223107a240a1ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2509771962","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509771962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509771962?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:58","pubTimestamp":1738853908,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时58分,Cellectar Biosciences, Inc.股票出现波动,股价快速拉升5.50%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为4935.47%、1062.42%、125.87%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为90.69%、39.93%、36.09%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225828a23bd4bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225828a23bd4bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2508446320","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.38%报0.276美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508446320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508446320?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:05","pubTimestamp":1738681517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时05分,Cellectar Biosciences, Inc.股票出现波动,股价快速拉升5.38%。截至发稿,该股报0.276美元/股,成交量14.4273万股,换手率0.31%,振幅4.31%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.96%。其相关个股中,Evaxion Biotech As、Azitra Inc、Regulus Therapeutics Inc.涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为1408.04%、850.75%、218.05%,振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025,振幅分别为60.25%、49.88%、40.00%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230517987a506b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230517987a506b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2508417501","title":"Cellectar Biosciences, Inc.盘中异动 大幅上涨6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508417501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508417501?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:54","pubTimestamp":1738594443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时54分,Cellectar Biosciences, Inc.股票出现波动,股价快速拉升6.60%。截至发稿,该股报0.268美元/股,成交量26.6476万股,换手率0.58%,振幅7.76%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为437.20%、367.60%、237.18%,振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.,振幅分别为97.05%、50.76%、39.98%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225403abc10c6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225403abc10c6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2507543254","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507543254?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:24","pubTimestamp":1738081494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时24分,Cellectar Biosciences, Inc.股票出现波动,股价急速下跌5.32%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp、Transcode Therapeutics, Inc.涨幅较大,Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为4311.50%、3308.47%、2197.71%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp,振幅分别为122.16%、102.05%、89.64%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129002455abbb7d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129002455abbb7d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2506630824","title":"Cellectar Biosciences, Inc.盘中异动 早盘急速下跌6.11%报0.243美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506630824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506630824?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988278,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分,Cellectar Biosciences, Inc.股票出现波动,股价快速下跌6.11%。截至发稿,该股报0.243美元/股,成交量13.9771万股,换手率0.34%,振幅0.00%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Akero Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、89Bio, Inc.涨幅较大,Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃,换手率分别为718.34%、39.56%、34.98%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Akero Therapeutics, Inc.、Biocardia, Inc.,振幅分别为11.62%、11.19%、10.50%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223118abba5f0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223118abba5f0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2506860558","title":"Cellectar Biosciences, Inc.盘中异动 早盘快速上涨5.00%报0.256美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506860558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506860558?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:10","pubTimestamp":1737735009,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时10分,Cellectar Biosciences, Inc.股票出现波动,股价快速上涨5.00%。截至发稿,该股报0.256美元/股,成交量68.5272万股,换手率1.66%,振幅6.11%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Neuphoria Therapeutics Inc.、Evaxion Biotech As、Pmgc Holdings Inc.涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为3808.46%、2062.67%、1533.94%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Neuphoria Therapeutics Inc.,振幅分别为134.08%、112.09%、107.98%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501250010099872151b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501250010099872151b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2503293919","title":"Cellectar Biosciences, Inc.盘中异动 急速跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503293919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503293919?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:42","pubTimestamp":1737042141,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时42分,Cellectar Biosciences, Inc.股票出现异动,股价快速下跌5.28%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为1759.51%、368.42%、246.66%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.,振幅分别为131.33%、76.46%、61.60%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623422198689bc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623422198689bc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2503647051","title":"Cellectar Biosciences, Inc.盘中异动 早盘快速下挫6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647051?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951468,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分,Cellectar Biosciences, Inc.股票出现异动,股价大幅跳水6.95%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Os Therapies Incorporated、Exicure, Inc.、Eterna Therapeutics Inc.涨幅较大,Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃,换手率分别为183.55%、55.23%、50.88%,振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Viracta Therapeutics, Inc.,振幅分别为10.72%、9.31%、9.18%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223109a222fd7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223109a222fd7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2503571279","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅跳水5.18%报0.267美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503571279?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:35","pubTimestamp":1736865334,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时35分,Cellectar Biosciences, Inc.股票出现波动,股价快速下挫5.18%。截至发稿,该股报0.267美元/股,成交量47.7264万股,换手率1.16%,振幅2.84%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Eterna Therapeutics Inc.、Azitra Inc、Silo Pharma, Inc.较为活跃,换手率分别为135.13%、58.96%、46.69%,振幅较大的相关个股有Eterna Therapeutics Inc.、Fate Therapeutics, Inc.、Lexaria Bioscience Corp.,振幅分别为70.42%、20.93%、20.87%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422353498660365&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422353498660365&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2503583198","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503583198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503583198?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778704,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分,Cellectar Biosciences, Inc.股票出现波动,股价大幅上涨5.56%。截至发稿,该股报0.298美元/股,成交量1522.66万股,换手率36.90%,振幅0.53%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.01%。其相关个股中,Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为2580.35%、1596.43%、389.66%,振幅较大的相关个股有Verrica制药、天境生物、Okyo Pharma Ltd Com Npv ,振幅分别为106.80%、106.67%、101.76%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223144a2203ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223144a2203ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2502597867","title":"Cellectar Biosciences, Inc.盘中异动 早盘急速下跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502597867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502597867?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:35","pubTimestamp":1736519730,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时35分,Cellectar Biosciences, Inc.股票出现异动,股价快速跳水5.37%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.70%。其相关个股中,Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Zyversa Therapeutics, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃,换手率分别为991.86%、144.66%、144.35%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.,振幅分别为27.56%、22.22%、20.34%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223530aba603cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223530aba603cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2501755527","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501755527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501755527?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:39","pubTimestamp":1736347153,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时39分,Cellectar Biosciences, Inc.股票出现波动,股价急速下挫5.88%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Sana Biotechnology, Inc.、Silo Pharma, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为1408.53%、533.96%、507.00%,振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为135.78%、84.85%、68.53%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223913aba34d1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223913aba34d1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2501257457","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501257457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501257457?lang=zh_cn&edition=full","pubTime":"2025-01-07 01:02","pubTimestamp":1736182929,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日01时02分,Cellectar Biosciences, Inc.股票出现波动,股价大幅拉升5.04%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Scisparc Ltd.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Alpha Tau Medical Ltd C/Wts 涨幅较大,Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为1535.90%、353.37%、144.04%,振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为176.15%、106.67%、92.16%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107010210aba0a947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107010210aba0a947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2500317148","title":"Cellectar Biosciences, Inc.盘中异动 急速上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500317148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500317148?lang=zh_cn&edition=full","pubTime":"2025-01-03 23:34","pubTimestamp":1735918489,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日23时34分,Cellectar Biosciences, Inc.股票出现异动,股价急速拉升5.57%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cyclacel Pharmaceuticals, Inc.涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为1611.14%、1356.66%、297.64%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.,振幅分别为143.91%、107.01%、96.04%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103233449ab9d68de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103233449ab9d68de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":0.0708},{"period":"1month","weight":0.2607},{"period":"3month","weight":-0.8029},{"period":"6month","weight":-0.8531},{"period":"1year","weight":-0.907},{"period":"ytd","weight":0.0415}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.1821},{"period":"ytd","weight":0.0236}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日,公司更名为现在的名字。该公司是一家后期临床生物制药公司,专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联物递送平台开发PDC,这些PDC旨在专门针对癌细胞,并由于更少的脱靶效应而提供更好的功效和更好的安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.010906},{"month":2,"riseRate":0.636364,"avgChangeRate":0.033448},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02847},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095326},{"month":5,"riseRate":0.3,"avgChangeRate":0.04729},{"month":6,"riseRate":0.4,"avgChangeRate":-0.071836},{"month":7,"riseRate":0.3,"avgChangeRate":-0.074001},{"month":8,"riseRate":0.4,"avgChangeRate":-0.015388},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.040633},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.138405},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.073945},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.052459}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.1","shortVersion":"4.31.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}